Membrane-Bound Transcription Factor Site-1 Protease in PF429242 Bound State: Computational Kinetics and Dynamics of Reversible Binding

Abstract

Membrane-bound transcription factor site-1 protease (S1P) is an emerging clinical target due to its roles in lipogenesis, lysosomal biogenesis, unfolded protein response and viral glycoprotein processing. In this study, homology model of S1P was created in order to understand the structural basis for S1P inhibition by PF429242 using molecular docking, molecular dynamics simulation and in silico kinetics studies. PF429242 was docked (GlideScore_PF429242=−5.20 kcal/mol) into the catalytic triad (D218, H249 and S414) and validated (R²=0.5686). The reversible binding kinetic parameter (K_off/K_on) was estimated at=7.28E-⁰³ M with fully bound and apo-states interspersed by 3 transient ligand-bound states with unique binding signatures; water plays a major role in PF429242 dissociation from the catalytic site. Communication between key catalytic triad residues is altered in the presence of PF429242. In apo-S1P state, S414–S307/V216-D218 is the preferred route but in PF429242-bound state, S414-S417/V216-D218 is preferred. Communication between S414 and H249 is also shortened in PF429242 bound state; here, only L410 is required unlike apo-state, which requires P418, V256 and F252. Ligand binding did not alter the communication route between S414 and H249 as both recruited D244 and G220. In conclusion, PF429242 binds tightly but reversible to S1P and the details of this interaction has been presented to guide future efforts at developing novel inhibitors. Site-1-protease; PF429242; Kon/Koff; Network analysis

Key words

antiviral drugs - chemical biology - drug receptor mechanisms

• References

• 1 Seidah NG, Prat A. Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem 2002; 38: 79-94
• 2 da Palma JR, Cendron L, Seidah NG. et al. Mechanism of folding and activation of subtilisin kexin isozyme-1 (ski-1)/site-1 protease (s1p). J Biol Chem 2016; 291: 2055-2066
• 3 Hawkins JL, Robbins MD, Warren LC. et al. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. J Pharmacol Exp Ther 2008; 326: 801-808
• 4 Caruana BT, Skoric A, Brown AJ. et al. Site-1 protease, a novel metabolic target for glioblastoma. Biochem Biophys Res Commun 2017; 490: 760-766
• 5 Yang J, Goldstein JL, Hammer RE. et al. Decreased lipid synthesis in livers of mice with disrupted site-1 protease gene. Proc Natl Acad Sci USA 2001; 98: 13607-13612
• 6 Seidah NG, Abifadel M, Prost S. et al. The proprotein convertases in hypercholesterolemia and cardiovascular diseases: Emphasis on proprotein convertase subtilisin/kexin 9. Pharmacol Rev 2017; 69: 33-52
• 7 Hyrina A, Meng F, McArthur SJ. et al. Human subtilisin kexin isozyme-1 (ski-1)/site-1 protease (s1p) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents. PLoS One 2017; 12: e0174483
• 8 Uchida L, Urata S, Ulanday GE. et al. Suppressive effects of the site 1 protease (s1p) inhibitor, pf-429242, on dengue virus propagation. Viruses 2016; 8 (46) 1-12
• 9 Oppliger J, da Palma JR, Burri DJ. et al. A molecular sensor to characterize arenavirus envelope glycoprotein cleavage by subtilisin kexin isozyme 1/site 1 protease. J Virol 2015; 90: 705-714
• 10 Hay BA, Abrams B, Zumbrunn AY. et al. Aminopyrrolidineamide inhibitors of site-1 protease. Bioorg Med Chem Lett 2007; 17: 4411-4414
• 11 Basak A, Mitra D, Das AK. et al. C(2)-symmetric azobenzene-amino acid conjugates and their inhibition of subtilisin kexin isozyme-1. Bioorg Med Chem Lett 2010; 20: 3977-3981
• 12 Chan JC, Piper DE, Cao Q. et al. A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates. Proc Natl Acad Sci USA 2009; 106: 9820-9825
• 13 Kobayashi H, Yoshida T, Miyakawa T. et al. Structural basis for action of the external chaperone for a propeptide-deficient serine protease from aeromonas sobria. J Biol Chem 2015; 290: 11130-11143
• 14 Doerr S, Harvey MJ, Noe F. et al. Htmd: High-throughput molecular dynamics for molecular discovery. J Chem Theory Comput 2016; 12: 1845-1852
• 15 Omotuyi OI, Nagai J, Ueda H. Lys39-lysophosphatidate carbonyl oxygen interaction locks lpa1 n-terminal cap to the orthosteric site and partners arg124 during receptor activation. Sci Rep 2015; 5: 13343
• 16 Huang J, MacKerell Jr. AD. Charmm36 all-atom additive protein force field: Validation based on comparison to nmr data. J Comput Chem 2013; 34: 2135-2145
• 17 Stanley N, Pardo L, Fabritiis GD. The pathway of ligand entry from the membrane bilayer to a lipid g protein-coupled receptor. Sci Rep 2016; 6: 22639
• 18 Harvey MJ, Giupponi G, Fabritiis GD. Acemd: Accelerating biomolecular dynamics in the microsecond time scale. J Chem Theory Comput 2009; 5: 1632-1639
• 19 Buch I, Giorgino T, De Fabritiis G. Complete reconstruction of an enzyme-inhibitor binding process by molecular dynamics simulations. Proc Natl Acad Sci USA 2011; 108: 10184-11018
• 20 DeLano WL. Pymol: An open-source molecular graphics tool. CCP4 Newsletter On Protein Crystallography 2002; 40: 82-92
• 21 Humphrey W, Dalke A, Schulten K. Vmd: Visual molecular dynamics. J Mol Graph 1996; 14: 33-38 27-38
• 22 Sethi A, Eargle J, Black AA. et al. Dynamical networks in trna:Protein complexes. Proc Natl Acad Sci U S A 2009; 106: 6620-6625
• 23 Nakagawa T, Suzuki-Nakagawa C, Watanabe A. et al. Site-1 protease is required for the generation of soluble (pro)renin receptor. J Biochem 2017; 161: 369-379
• 24 Urata S, Yun N, Pasquato A. et al. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J Virol 2011; 85: 795-803
• 25 Friesner RA, Murphy RB, Repasky MP. et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem 2006; 49: 6177-6196
• 26 Noe F, Wu H, Prinz JH. et al. Projected and hidden markov models for calculating kinetics and metastable states of complex molecules. J Chem Phys 2013; 139: 184114
• 27 Corzo J. Time, the forgotten dimension of ligand binding teaching. Biochem Mol Biol Educ 2006; 34: 413-416
• 28 Dahms SO, Arciniega M, Steinmetzer T. et al. Structure of the unliganded form of the proprotein convertase furin suggests activation by a substrate-induced mechanism. Proc Natl Acad Sci USA 2016; 113: 11196-11201
• 29 Hardes K, Becker GL, Lu Y. et al. Novel furin inhibitors with potent anti-infectious activity. ChemMedChem 2015; 10: 1218-1231
• 30 Longhi S, Nicolas A, Creveld L. et al. Dynamics of fusarium solani cutinase investigated through structural comparison among different crystal forms of its variants. Proteins 1996; 26: 442-458
• 31 Lau EY, Bruice TC. Consequences of breaking the asp-his hydrogen bond of the catalytic triad: Effects on the structure and dynamics of the serine esterase cutinase. Biophys J 1999; 77: 85-98